ESR1 and meningioma: After analysis of the data from two and 24 articles, respectively, 6% of meningiomas developed under hormonal treatment expressed estrogen receptors (95% CI: 0.1–11.9) vs. 11% of meningiomas developed without any hormonal treatment (95% CI: 5.9–17.5).